Benzinga | May 12, 2021 06:09AM EDT

Inozyme Pharma Q1 EPS $(0.47) Up From $(6.42) YoY

Inozyme Pharma (NASDAQ:INZY) reported quarterly losses of $(0.47) per share. This is a 92.68 percent increase over losses of $(6.42) per share from the same period last year.